Bayer sheds some brands to focus on pharma and fight pesticide claims
Bayer sheds some brands to focus on pharma and fight pesticide claims
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been growing since buying Monsanto earlier this year. Sounds good, but there’s a lingering problem that came with the Monsanto deal: Thousands of people have filed claims saying one of the company’s pesticides gave them cancer.
Click the audio player above to hear the full story.
Stories You Might Like
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
